Patrick Beyrer

China and Trade @McLartyAssoc | Non-Resident Research Associate on Chinese Tech and Public Health @AsiaPolicy | opinions my own

[Patrick Beyrer @patbeyrer]

How has US-China biotechnology competition evolved and what are the stakes?

Excited to share my latest with @AsiaPolicy tracking new developments in this emerging frontier of US-China tech rivalry. /1

https://t.co/jOjvC2oRh6

[Neil Thomas 牛犇 @neilthomas123]

What are the core dilemmas shaping China’s trajectory in 2026?

Our new @AsiaPolicy report shows a China that is dynamic yet constrained—balancing control with vitality, security with development, ambition with caution, and resilience with fragility

What Will Xi Jinping's Priorities Be in 2026?
—Myself & Lobsang Tsering

How Will the Next Generation of Chinese Leaders Reconcile Effective Governance and Party Loyalty?
— @guoguang_wu

Can China Reconcile Private-Sector Vitality with State-Led Innovation?
— @wstv_lizzi

Can Beijing Truly Pivot Toward a Consumption-Led Economy?
— @choyleva

Can the United States and China Find a New Equilibrium on Trade and Technology?
—Brendan Kelly & @MichaelHirson

How Does Beijing Read U.S. Power—and How Will It Shape China's Foreign Policy Posture?
— @sungminchohi & @PhLeCorre

Will Beijing Recalibrate Its Approach to Taiwan?
— @LyleJMorris

Can Beijing Contain Public Frustration over High Inequality, Youth Unemployment, and Economic Strain?
— @barclaybram

Can Beijing Preserve Growth and Stability amid Rapid Demographic Change?
— @DrEmmaZang

Can China Sustain Its Rise as a Global Pharmaceutical Innovator?
— @patbeyrer & Chang Liu

Will China Assume Greater Climate Leadership in Light of U.S. Retreat?
— @LiShuo_GP

Can China Turn Its Clean Energy Dominance into Green Soft Power?
— @Kate_K_Logan

[Gerard DiPippo @gdp1985]

Where does the US-China trade war go from here? On tariffs, US will continue with 232s and prep new 301s; I think existing 301 can cover China. But tariffs could be on the back burner in the near term. New focus for US-China is export controls. 1/

[Ryan Hass @ryanl_hass]

1/ Secretary Lutnick’s message is important for setting expectations. Chinese President Jiang Zemin sent a telegram of condolence to George W Bush on September 11, 2001, but beyond that, it is exceedingly rare for a PRC leader to initiate outreach to a US president. (🧵)

[The Wall Street Journal @WSJ]

A congressional commission warned that China is making big strides in biotechnology and the U.S. must invest more in research and take other steps to protect its national security https://t.co/N18mFVhM3K

[Bloomberg @business]

Here comes the booming Chinese biotech sector https://t.co/CosV2jWxii

[Patrick Beyrer @patbeyrer]

@AsiaSociety And with today’s news from China, understanding great power biotech rivalry between Washington and Beijing is even more critical.
For more, see my @AsiaPolicy piece last spring detailing the state of US-China biotech competition: https://t.co/xPXnSLvjWG

[Patrick Beyrer @patbeyrer]

Pleased to publish a new @AsiaSociety report on #WorldCancerDay.

Drawing on the work of scientists, policymakers, and more, this report identifies the challenges and opportunities within US-China scientific ties to change cancer care as we know it. 🧵
https://t.co/EWtf8VyVvG

[Patrick Beyrer @patbeyrer]

@AsiaSociety Progress on joint cancer trials can help overcome structural challenges within US-China tensions while delivering on a global public good for humanity. Coordinating a practical bilateral framework, despite legitimate obstacles, holds the potential to save millions of lives. 14/